Immune receptor inhibition through enforced phosphatase recruitment
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immune receptor inhibition through enforced phosphatase recruitment
Authors
Keywords
-
Journal
NATURE
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-10-22
DOI
10.1038/s41586-020-2851-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molecular mechanism of SHP2 activation by PD-1 stimulation
- (2020) M. Marasco et al. Science Advances
- Tuning the Antigen Density Requirement for CAR T-cell Activity
- (2020) Robbie G. Majzner et al. Cancer Discovery
- 2017–2018 Scientific Advances in Thoracic Oncology: Small Cell Lung Cancer
- (2019) Stefan Zimmerman et al. Journal of Thoracic Oncology
- Depletion of PD-1-positive cells ameliorates autoimmune disease
- (2019) Peng Zhao et al. Nature Biomedical Engineering
- Discovery of high affinity, pan-allelic, and pan-mammalian reactive antibodies against the myeloid checkpoint receptor SIRPα
- (2019) Janet Sim et al. mAbs
- Phosphorylation of PD-1-Y248 is a marker of PD-1-mediated inhibitory function in human T cells
- (2019) Kankana Bardhan et al. Scientific Reports
- c-Jun overexpression in CAR T cells induces exhaustion resistance
- (2019) Rachel C. Lynn et al. NATURE
- Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations
- (2018) Jun Gong et al. Journal for ImmunoTherapy of Cancer
- Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
- (2018) Spencer C. Wei et al. Cancer Discovery
- Organoid Modeling of the Tumor Immune Microenvironment
- (2018) James T. Neal et al. CELL
- Unravelling the biology of SCLC: implications for therapy
- (2017) Joshua K. Sabari et al. Nature Reviews Clinical Oncology
- T cell costimulatory receptor CD28 is a primary target for PD-1–mediated inhibition
- (2017) Enfu Hui et al. SCIENCE
- Initiation of T cell signaling by CD45 segregation at 'close contacts'
- (2016) Veronica T Chang et al. NATURE IMMUNOLOGY
- Streamlined method for parallel identification of single domain antibodies to membrane receptors on whole cells
- (2015) Martín Rossotti et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- “Velcro” Engineering of High Affinity CD47 Ectodomain as Signal Regulatory Protein α (SIRPα) Antagonists That Enhance Antibody-dependent Cellular Phagocytosis
- (2015) Chia Chi M. Ho et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Clinical Scale Zinc Finger Nuclease-mediated Gene Editing of PD-1 in Tumor Infiltrating Lymphocytes for the Treatment of Metastatic Melanoma
- (2015) Joal D Beane et al. MOLECULAR THERAPY
- Comprehensive genomic profiles of small cell lung cancer
- (2015) Julie George et al. NATURE
- Strength of PD-1 signaling differentially affects T-cell effector functions
- (2013) F. Wei et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Engineered SIRP Variants as Immunotherapeutic Adjuvants to Anticancer Antibodies
- (2013) K. Weiskopf et al. SCIENCE
- Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape
- (2011) S.-R. Woo et al. CANCER RESEARCH
- Early T Cell Signalling Is Reversibly Altered in PD-1+ T Lymphocytes Infiltrating Human Tumors
- (2011) Shu-Fang Wang et al. PLoS One
- T Cell Activation
- (2009) Jennifer E. Smith-Garvin et al. Annual Review of Immunology
- Large-Scale Structural Analysis of the Classical Human Protein Tyrosine Phosphatome
- (2009) Alastair J. Barr et al. CELL
- PD-1 signaling in primary T cells
- (2009) James L. Riley IMMUNOLOGICAL REVIEWS
- Single-domain antibody fragments with high conformational stability
- (2002) Mireille Dumoulin et al. PROTEIN SCIENCE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started